A phase 1 single center, open label, fixed sequence, parallel group study evaluating pharmacokinetic drug-drug interaction of single oral doses of midazolam and caffeine with 10 and 25 mg obeticholic acid in healthy subjects
Latest Information Update: 28 Aug 2017
Price :
$35 *
At a glance
- Drugs Obeticholic acid (Primary) ; Caffeine; Midazolam
- Indications Primary biliary cirrhosis
- Focus Pharmacokinetics
- 28 Aug 2017 New trial record
- 14 Aug 2017 Results published in the Advances in Therapy